Clinical Trial Update: A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SHR-A2102 in combination with Adebrelimab and SHR-8068 for locally advanced or metastatic non-small cell lung cancer. The study is in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068
• SHR-A2102

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING